Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Diakine-DK210 (EGFR) by Deka Biosciences for Squamous Cell Carcinoma: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Squamous Cell Carcinoma. According to...
Diakine-DK210 (EGFR) by Deka Biosciences for Skin Cancer: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Skin Cancer. According to GlobalData,...
Diakine-DK210 (EGFR) by Deka Biosciences for Non-Small Cell Lung Cancer: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Non-Small Cell Lung Cancer. According...
Diakine-DK210 (EGFR) by Deka Biosciences for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Kidney Cancer (Renal Cell Cancer)....
Diakine-DK210 (EGFR) by Deka Biosciences for Solid Tumor: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Solid Tumor. According to GlobalData,...
Diakine-DK210 (EGFR) by Deka Biosciences for Bladder Cancer: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Bladder Cancer. According to GlobalData,...
Diakine-DK210 (EGFR) by Deka Biosciences for Pancreatic Cancer: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Pancreatic Cancer. According to GlobalData,...
Diakine-DK210 (EGFR) by Deka Biosciences for Head And Neck Cancer: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Head And Neck Cancer. According...
Diakine-DK210 (EGFR) by Deka Biosciences for Colorectal Cancer: Likelihood of Approval
Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Colorectal Cancer. According to GlobalData,...